Related Experiment Video
Updated: May 5, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox
Dennis T Ko1, Muhammad Mamdani, David A Alter
1Division of Cardiology, Schulich Heart Centre, and Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario.
JAMA
|April 22, 2004
Summary
Physicians prescribed statins less often to high-risk patients, despite evidence showing statin benefits for secondary cardiovascular prevention. Optimal statin use requires prioritizing high-risk individuals to maximize cardiovascular health outcomes.
Area of Science:
- Cardiology
- Health Services Research
- Public Health
Background:
- Cardiovascular therapies, including statins, are crucial for secondary prevention.
- Optimal utilization of these therapies should align with patient cardiovascular risk.
- Current practices may not fully leverage statins in high-risk populations.
Purpose of the Study:
- To investigate the relationship between physician treatment intensity and patient baseline cardiovascular risk.
- To determine if statin prescription patterns correlate with predicted cardiovascular risk.
Main Methods:
- Retrospective cohort study using linked healthcare administrative databases in Ontario.
- Included 396,077 patients aged 66+ with cardiovascular disease or diabetes.
- Baseline risk modeled using a 3-year mortality prediction index.
Main Results:
- Only 19.1% of the secondary prevention cohort received statins.
- Statin prescription rates decreased as baseline cardiovascular risk and predicted mortality increased.
- Age and baseline risk interacted, with older patients and higher risk showing lower statin use.
Conclusions:
- Statin prescription was inversely associated with cardiovascular risk and predicted mortality.
- Maximum benefits of statins may be unrealized due to underutilization in highest-risk patients.
- Implementation of statin therapy needs to prioritize individuals with the greatest cardiovascular risk.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:15Drug Dosing: Geriatric Patients
400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
387
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
387
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
405
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
405
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747